Rapid Sequence Induction
12
1
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.3%
1 terminated out of 12 trials
85.7%
-0.8% vs benchmark
25%
3 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Comparison of High-Flow Nasal Cannula and Tight Face Mask for Maintaining Oxygenation During Rapid Sequence Induction
Impact of Opioids on Heart Rate During Rapid Sequence Intubation
High-flow Nasal Cannula Oxygenation During Rapid Sequence Induction in Children
Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room
RSI Observation Follow-up
Preoxygenation With High-flow Nasal Oxygen in Adult Trauma Patients During Rapid Sequence Induction Anaesthesia
Rapid Sequence Intubation With Rocuronium in Elderly Patients
Rapid Sequence Induction: Succinyl Choline vs Rocuronium After Pretreatment With Dexmedetomidine
Classic and Modified Rapid Sequence Induction for Prevention of Gastric Content Regurgitation
Rapid Sequence Induction EU: Electronic Survey (RSIEU)
EUROpE-RSI (EURopean Online Evaluation RSI Study)
Rapid Sequence Induction Czech Republic: Survey